دورية أكاديمية

Proteomic comparison between non‐purified cerebrospinal fluid and cerebrospinal fluid‐derived extracellular vesicles from patients with Alzheimer's, Parkinson's and Lewy body dementia.

التفاصيل البيبلوغرافية
العنوان: Proteomic comparison between non‐purified cerebrospinal fluid and cerebrospinal fluid‐derived extracellular vesicles from patients with Alzheimer's, Parkinson's and Lewy body dementia.
المؤلفون: Hirschberg, Yael, Valle‐Tamayo, Natalia, Dols‐Icardo, Oriol, Engelborghs, Sebastiaan, Buelens, Bart, Vandenbroucke, Roosmarijn E., Vermeiren, Yannick, Boonen, Kurt, Mertens, Inge
المصدر: Journal of Extracellular Vesicles; Dec2023, Vol. 12 Issue 12, p1-22, 22p
مصطلحات موضوعية: LEWY body dementia, PARKINSON'S disease, CEREBROSPINAL fluid, EXTRACELLULAR vesicles, CEREBROSPINAL fluid examination, ALZHEIMER'S patients
مستخلص: Dementia is a leading cause of death worldwide, with increasing prevalence as global life expectancy increases. The most common neurodegenerative disorders are Alzheimer's disease (AD), dementia with Lewy bodies (DLB) and Parkinson's disease dementia (PDD). With this study, we took an in‐depth look at the proteome of the (non‐purified) cerebrospinal fluid (CSF) and the CSF‐derived extracellular vesicles (EVs) of AD, PD, PD‐MCI (Parkinson's disease with mild cognitive impairment), PDD and DLB patients analysed by label‐free mass spectrometry. This has led to the discovery of differentially expressed proteins that may be helpful for differential diagnosis. We observed a greater number of differentially expressed proteins in CSF‐derived EV samples (N = 276) compared to non‐purified CSF (N = 169), with minimal overlap between both datasets. This finding suggests that CSF‐derived EV samples may be more suitable for the discovery phase of a biomarker study, due to the removal of more abundant proteins, resulting in a narrower dynamic range. As disease‐specific markers, we selected a total of 39 biomarker candidates identified in non‐purified CSF, and 37 biomarker candidates across the different diseases under investigation in the CSF‐derived EV data. After further exploration and validation of these proteins, they can be used to further differentiate between the included dementias and may offer new avenues for research into more disease‐specific pharmacological therapeutics. [ABSTRACT FROM AUTHOR]
Copyright of Journal of Extracellular Vesicles is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
قاعدة البيانات: Complementary Index
الوصف
تدمد:20013078
DOI:10.1002/jev2.12383